McKesson Corp.

Company Overview

Founded in1833, McKesson Corp. is a leader in diverse healthcare services committed to improving patient outcomes all across the world. Its teams collaborate with biopharma firms, healthcare organizations, pharmacies, manufacturers, and other parties to produce insights, goods, and services that contribute to the accessibility and affordability of high-quality healthcare.

The company operates through four business segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International.

In addition to other healthcare-related products, the U.S. Pharmaceutical division offers customers distribution and logistical services for branded, generic, specialty, biosimilar, and OTC pharmaceutical medications.

In the United States and Puerto Rico, this company offers solutions and services to pharmacies, hospitals, oncology practices, and other specialized clinics, pharmaceutical makers, biopharma partners, doctors, payers, and patients. Through its joint venture with Walmart, ClarusONE Sourcing Services LLP (“ClarusONE”), it also sources generic pharmaceuticals.

Regardless of insurance coverage, its Prescription Technology Solutions business connects pharmacies, healthcare providers, payers, and biopharmaceutical firms to deliver medication access and adherence solutions that assist patients from initial prescription fill to ongoing therapy.

Its Medical-Surgical Solutions division provides healthcare providers across the range of alternate sites with medical supply distribution, logistics, biomedical maintenance, and other services. Among its clients are doctor’s offices, operating rooms, post-acute care institutions, hospital reference labs, and home health organizations. To support its main target end-markets, such as primary care, extended care, government, and other markets, it collaborates with manufacturers and channel partners. It sells infusion pumps, laboratory equipment, medications, and medical surgical supplies like gloves, needles, syringes, and wound care items.

In 11 European countries where it owns, partners with, or franchises retail pharmacies, its International sector offers distribution and services to wholesale, institutional, and retail customers through its two businesses, Pharmaceutical Distribution, and Retail Pharmacy.

Revenues for the fiscal year ending March 31, 2022, at Medical-Surgical Solutions climbed 15% over the preceding year, primarily in its primary care segment, due to increases in patient care visits. The contribution from the kitting and delivery of supplemental supplies for COVID-19 vaccines had a positive effect on this segment’s revenues as well.

Financial Highlights (FY 2023)

Company's Business Segments

• U.S. Pharmaceutical : U.S. Pharmaceutical segment provides Distribution, Logistics Services for Branded, Generic, Specialty, Biosimilar, OTC Pharmaceutical Drugs along with Other Healthcare-related Products to customers.
• Prescription Technology Solutions : Prescription Technology Solutions segment works across Healthcare to connect Patients, Pharmacies, Providers, Pharmacy benefit Managers, Health Plans, Biopharma to deliver medication access solutions that support patients from first prescription fill to Ongoing Therapy, regardless of their insurance coverage.
• Medical-Surgical Solutions : Medical-Surgical Solutions segment delivers Medical-supply Distribution, Logistics, Biomedical Maintenance, Other services to Healthcare providers across the alternate-site spectrum.
• International : International segment provides Distribution, Services to Wholesale, Institutional, Retail Customers in Canada, Europe where we Own, Partner, Franchise with Retail Pharmacies.